We are live on ! Find out more
MWVC

Morgens Waterfall Vintiadis & Co Portfolio holdings

AUM $81.2M
1-Year Est. Return 86.87%
This Fund
S&P 500
This Quarter Est. Return
-17.68%
1 Year Est. Return
+86.87%
3 Year Est. Return
+484.3%
5 Year Est. Return
+875.12%
10 Year Est. Return
+12,893.79%
AUM
$112M
AUM Growth
-$40.5M
Cap. Flow
-$15.5M
Cap. Flow %
-13.76%
Top 10 Hldgs %
37.89%
Holding
75
New
19
Increased
7
Reduced
11
Closed
16

Top Sells

Rank Stock Value
1
XYZ
Block Inc
XYZ
+$7.43M
2
XPO icon
XPO
XPO
+$5.94M
3
CZR icon
Caesars Entertainment
CZR
+$5.64M
4
TDOC icon
Teladoc Health
TDOC
+$3.89M
5
BABA icon
Alibaba
BABA
+$3.79M

Sector Composition

Rank Sector Weight
1 Technology 37.15%
2 Consumer Discretionary 24.48%
3 Healthcare 12.12%
4 Communication Services 9.68%
5 Industrials 4.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UNH icon
26
UnitedHealth
UNH
$378B
$2.49M 2.22%
10,000
-100
-1% -$26.4K
BA icon
27
Boeing
BA
$184B
$2.45M 2.18%
+7,600
New +$2.63M
HD icon
28
Home Depot
HD
$337B
$1.82M 1.62%
10,600
RETA
29
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$1.79M 1.6%
32,000
ILMN icon
30
Illumina
ILMN
$30.2B
$1.5M 1.33%
5,140
EHTH icon
31
eHealth
EHTH
$44.8M
$1.5M 1.33%
39,000
V icon
32
Visa
V
$684B
$1.32M 1.17%
10,000
+5,000
+100% +$691K
VCRA
33
DELISTED
VOCERA COMMUNICATIONS, INC.
VCRA
$1.24M 1.1%
31,500
-9,500
-23% -$344K
MA icon
34
Mastercard
MA
$504B
$1.23M 1.09%
6,500
BEAT
35
DELISTED
BioTelemetry, Inc.
BEAT
$1.1M 0.98%
18,500
MDSO
36
DELISTED
Medidata Solutions, Inc.
MDSO
$1.04M 0.92%
15,400
TRHC
37
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
$1.02M 0.91%
16,000
HRTX icon
38
Heron Therapeutics
HRTX
$96.7M
$1.01M 0.9%
39,000
ADMA icon
39
ADMA Biologics
ADMA
$2B
$956K 0.85%
400,000
+25,000
+7% +$124K
CRM icon
40
Salesforce
CRM
$153B
$685K 0.61%
+5,000
New +$688K
DIS icon
41
Walt Disney
DIS
$170B
$658K 0.59%
+6,000
New +$682K
ABT icon
42
Abbott
ABT
$185B
$651K 0.58%
+9,000
New +$633K
AAPL icon
43
Apple
AAPL
$4.48T
$631K 0.56%
16,000
-7,752
-33% -$376K
SO icon
44
Southern Company
SO
$108B
$615K 0.55%
+14,000
New +$636K
OMCL icon
45
Omnicell
OMCL
$1.69B
$612K 0.54%
+10,000
New +$677K
PFE icon
46
Pfizer
PFE
$142B
$567K 0.5%
13,702
AZN icon
47
AstraZeneca
AZN
$243B
$490K 0.44%
6,450
+350
+6% +$27.3K
MRK icon
48
Merck
MRK
$315B
$477K 0.42%
+6,540
New +$462K
BP icon
49
BP
BP
$114B
$475K 0.42%
12,930
-196
-1% -$7.83K
RDS.B
50
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
$467K 0.42%
7,792

Similar funds

Morgens Waterfall Vintiadis & Co's Q4 2018 Portfolio in Review

As of Q4 2018, Morgens Waterfall Vintiadis & Co held 75 positions worth $112M, down 26% from $153M the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Morgens Waterfall Vintiadis & Co withdrew a net $15.5M in Q4 2018, closing 16 positions and reducing 11 holdings. Its most notable exit was Block Inc, an estimated $7.43M position sold in full.

By sector, the portfolio is most concentrated in Technology at 37% of assets, down from 43% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Morgens Waterfall Vintiadis & Co opened a new position in ON Semiconductor worth $3.47M.

  • Morgens Waterfall Vintiadis & Co's largest Q4 2018 buy was ON Semiconductor: 210,000 shares worth $3.47M.
  • Morgens Waterfall Vintiadis & Co added most to Advanced Micro Devices in Q4 2018, an estimated $865K increase.
  • Morgens Waterfall Vintiadis & Co's biggest Q4 2018 reduction was Okta, cutting an estimated $1.78M.
  • Morgens Waterfall Vintiadis & Co fully exited Block Inc in Q4 2018, selling an estimated $7.43M.
  • Morgens Waterfall Vintiadis & Co's ten largest holdings make up 38% of its $112M portfolio in Q4 2018.
  • Morgens Waterfall Vintiadis & Co opened 19 new positions and closed 16 in Q4 2018.
  • Morgens Waterfall Vintiadis & Co's portfolio value fell 26% quarter-over-quarter to $112M.

Based on Morgens Waterfall Vintiadis & Co's 13F filing for Q4 2018, filed 14 Feb 2019.